SEC Form 4 · accession 0001450324-16-000015
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas K. Equels
Officer — CEO,President · Director
Period of report
Nov 1, 2016
Accepted (ET)
Nov 1, 2016 · 1:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 1, 2016 | P | 10,000 | $1.00 | A | 151,962 | D |
Table II — derivative securities
No Table II lines on this filing.